1-β-d-Arabinofuranosylcytosine-5′-alkylphosphonophosphates and diphosphates: new orally active derivatives of ara-C - Journal of Lipid Research
Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of Kv1.3 potassium channels, AKT and ERK1/2 signaling | Cell Communication and Signaling | Full Text
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C | Leukemia
Cytarabine Images – Browse 115 Stock Photos, Vectors, and Video | Adobe Stock
5.600+ Fotos, Bilder und lizenzfreie Bilder zu Hellroter Ara - iStock
Cytarabin - Wirkung, Anwendung & Risiken | MedLexi.de
Entscheidende Fortschritte dank neuer Substanzen - Onkologie - Universimed - Medizin im Fokus
High-Dose Cytarabine (HD araC) in the Treatment of Leukemias: a Review | springermedizin.de
Cytarabin - Altmeyers Enzyklopädie - Fachbereich Dermatologie
Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis - ScienceDirect
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C | Leukemia
Cytarabine (Cytosine β-D-arabinofuranoside) | DNA Synthesis Inhibitor | MedChemExpress
PDF) Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/ macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: Final results of
P Langen's research works | Max-Delbrück-Centrum für Molekulare Medizin, Berlin (MDC) and other places
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study - The Lancet Oncology
Randomisierter Vergleich zwischen Standard- und intensivierter Therapiestrategie der akuten myeloischen Leukämie des Erwachsene
EHA-Highlights: Fokus AML - Onkologie - Universimed - Medizin im Fokus
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG | Leukemia
AML Akute myeloische Leukämie
Cytarabin (Cytosinarabinosid, Ara-C)-Chemotherapie-Arzneimittelmolekül. Zur Behandlung der: Stock-Vektorgrafik (Lizenzfrei) 2050245218 | Shutterstock
Cytarabine (Cytosine β-D-arabinofuranoside) | DNA Synthesis Inhibitor | MedChemExpress
